Loading organizations...
Loading organizations...
Neurology company focused on rare brain diseases and therapies.
Ovid Therapeutics has raised $80.0M across 2 funding rounds.
Ovid Therapeutics has raised $80.0M in total across 2 funding rounds.
Ovid Therapeutics has raised $80.0M in total across 2 funding rounds.
Ovid Therapeutics's investors include Fidelity Management & Research Company, Cormorant Asset Management, Cowen Private Investments, DoubleLine Equity Healthcare Fund, Jennison Associates, Redmile Group, Sanofi Ventures, Sphera Healthcare, Tekla Capital Management.
Ovid Therapeutics has raised $80.0M across 2 funding rounds. Most recently, it raised $75.0M Series B in August 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 11, 2015 | $75.0M Series B | Fidelity Management & Research Company | Cormorant Asset Management, Cowen Private Investments, DoubleLine Equity Healthcare Fund, Jennison Associates, Redmile Group, Sanofi Ventures, Sphera Healthcare, Tekla Capital Management |
| Mar 25, 2015 | $5.0M Other Equity |